"Recent Advances in Clinical Care and Research in Cystic Fibrosis" by Alex Gifford, MD
CF Foundation | 2017 VLC: New Advances in Characterizing and Correcting CFTR Mutations Round 2
NACFC 2021 | W31: Difficult to Treat CFTR Mutations, Novel Modulator, RNA Editing Tech to Fix CFTR
CPIC guideline for Ivacaftor and CFTR
CF Foundation | 2017 VLC: New Advances in Characterizing and Correcting CFTR Mutations Round 1
CFTR Cystic Fibrosis - 5 Mutation Classes
Communication with Patients about CFTR Mutation-based Therapy
CF, CFTR and Novel CF Therapies
ResearchCon 2020 | CF 101: Decoding CFTR Genetics to Transform Treatment
NACFC 2021 | Plenary 2: Working Together to Pave the Path to a Cure
ResearchCon 2020 | Therapeutic Approaches for Rare and Nonsense Mutations
Cystic Fibrosis and Cystic Fibrosis Medications Part 7
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
CF Foundation | 2017 NACFC Plenary 1: Matching Medicines With Mutations
Cystic Fibrosis and Cystic Fibrosis Medications Part 2
Therapies in Cystic Fibrosis Directed Towards Basic Defect
Cystic Fibrosis with Dr. Molly Howsare
ResearchCon 2020 | Beyond Modulators: Genetic Therapies on the Horizon
NACFC 2020 | Discipline Group 2: Optimizing Cystic Fibrosis Nutrition Care in a New Era